Market Overview

Rumor: Big Stake In Allergan Acquired By Valeant Supporter Paulson

Share:
Related VRX
Benzinga's Option Alert Recap From October 18
Benzinga's Option Alert Recap From October 17
The Vetr community has upgraded $VRX to 4.5-Stars. (Vetr)
Related AGN
The Market In 5 Minutes: Chaos In Catalonia, Black Monday's 30th Anniversary
Benzinga's Top Upgrades, Downgrades For October 19, 2017
Harvey Investment Co Llc Buys Hexcel Corp, DowDuPont Inc, Duke Energy Corp, Sells Allergan PLC, ... (GuruFocus)

Allergan Inc. (NYSE: AGN) shares bumped up more than 2 percent on a rumor that Hedge fund Paulson & Co. acquiredsix6 million shares.

The report by Reuters said Paulson backs Valeant Pharmaceuticals (NYSE: VRX) in its proxy battle to acquire Allergan and the new stake puts Paulson among Allergan's top holders.

Valeant needs support from 25 percent of Allergan's holders in order to call a special shareholder meeting to vote on its $53 billion bid.

Allergan has called the offer "grossly inadequate."

With a current market capitalization of about $50.3 billion, Allergan traded recently at $69.02, up 2.2 percent.

Posted-In: News Rumors

 

Related Articles (AGN + VRX)

View Comments and Join the Discussion!
Loading...

Partner Center

Loading...